EDITORIAL
Published on 14 Aug 2019
Editorial: Immunotherapy in Multiple Myeloma
doi 10.3389/fimmu.2019.01945
- 2,615 views
- 7 citations
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Immunotherapy in Multiple Myeloma
Immunotherapy in Multiple Myeloma
67k
Total downloads
266k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
REVIEW
Published on 24 Apr 2019
CD38 in Adenosinergic Pathways and Metabolic Re-programming in Human Multiple Myeloma Cells: In-tandem Insights From Basic Science to Therapy
doi 10.3389/fimmu.2019.00760
- 12,885 views
- 55 citations
REVIEW
Published on 28 Nov 2018
CD38: A Target for Immunotherapeutic Approaches in Multiple Myeloma
doi 10.3389/fimmu.2018.02722
- 55,166 views
- 143 citations
MINI REVIEW
Published on 27 Nov 2018
Promises and Pitfalls in the Use of PD-1/PD-L1 Inhibitors in Multiple Myeloma
doi 10.3389/fimmu.2018.02749
- 5,938 views
- 44 citations
ORIGINAL RESEARCH
Published on 27 Nov 2018
Enhancing the Activation and Releasing the Brakes: A Double Hit Strategy to Improve NK Cell Cytotoxicity Against Multiple Myeloma
doi 10.3389/fimmu.2018.02743
- 4,942 views
- 27 citations
ORIGINAL RESEARCH
Published on 19 Nov 2018
CD38-Specific Biparatopic Heavy Chain Antibodies Display Potent Complement-Dependent Cytotoxicity Against Multiple Myeloma Cells
doi 10.3389/fimmu.2018.02553
- 6,476 views
- 41 citations
REVIEW
Published on 16 Nov 2018
Update on PD-1/PD-L1 Inhibitors in Multiple Myeloma
doi 10.3389/fimmu.2018.02431
- 16,653 views
- 98 citations
REVIEW
Published on 15 Nov 2018
Blood Transfusion Management for Patients Treated With Anti-CD38 Monoclonal Antibodies
doi 10.3389/fimmu.2018.02616
- 34,240 views
- 48 citations
MINI REVIEW
Published on 06 Nov 2018
Vγ9Vδ2 T Cells as Strategic Weapons to Improve the Potency of Immune Checkpoint Blockade and Immune Interventions in Human Myeloma
doi 10.3389/fonc.2018.00508
- 3,604 views
- 16 citations
MINI REVIEW
Published on 06 Nov 2018
Perspectives for the Development of CD38-Specific Heavy Chain Antibodies as Therapeutics for Multiple Myeloma
doi 10.3389/fimmu.2018.02559
- 3,878 views
- 16 citations
REVIEW
Published on 05 Nov 2018
Mechanisms of NK Cell Activation and Clinical Activity of the Therapeutic SLAMF7 Antibody, Elotuzumab in Multiple Myeloma
doi 10.3389/fimmu.2018.02551
- 15,739 views
- 93 citations
REVIEW
Published on 24 Oct 2018
Role of Osteocytes in Myeloma Bone Disease: Anti-sclerostin Antibody as New Therapeutic Strategy
doi 10.3389/fimmu.2018.02467
- 6,439 views
- 35 citations
Published in
Frontiers in Immunology
- Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Impact
- 266kTopic views
- 195kArticle views
- 67kArticle downloads